REPORT: Judge Hammoud to LBCI: Pulmonary clot is behind death of Farah Qassab

Edmond Sassine Author: Edmond Sassine
Breaking Headlines
09-06-2017 | 12:29
High views
Share
LBCI
Share
LBCI
Whatsapp
facebook
Twitter
Messenger
telegram
telegram
print
REPORT: Judge Hammoud to LBCI: Pulmonary clot is behind death of Farah Qassab
Whatsapp
facebook
Twitter
Messenger
telegram
telegram
print
Whatsapp
facebook
Twitter
Messenger
telegram
telegram
print
2min
REPORT: Judge Hammoud to LBCI: Pulmonary clot is behind death of Farah Qassab
State Prosecutor Judge Samir Hammoud told LBCI on Friday that the reason behind the death of Iraqi national Farah Qassab is pulmonary clot.
 
This as Hammoud had earlier revealed during a phone call with the state-run National News Agency that the autopsy of Farah Qassab showed that the reason behind her death is a brain stroke.
 
The agency then corrected the news and said that Judge Hammoud has asserted that the reason of death is a pulmonary clot.
 
Hammoud also noted that investigations are still ongoing to reveal the reason behind the stroke and whether it could have been avoided.
 
He concluded by saying that the Public Prosecution is awaiting another report that will be issued by the Order of Physicians.
 
Investigations into the death of the Iraqi national Farah Qassab inside a beauty clinic in the region of Naccache during a plastic surgery performed by renowned plastic surgeon Nader Saab continued.

Dr. Saab says that Qassab arrived alive to the Notre Dame hospital in Jounieh while the hospital denies such statement and says that Farah arrived dead.

 
 
To watch the full report, please click on the video above.

Breaking Headlines

Plastic Surgery

Lebanon

LBCI Next
A patient at Notre Dame De Liban Hospital - Jounieh urgently needs A+ blood type, to donate please call: 70 281 616
Download now the LBCI mobile app
To see the latest news, the latest daily programs in Lebanon and the world
Google Play
App Store
We use
cookies
We use cookies to make
your experience on this
website better.
Accept
Learn More